Concepts (229)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Residence Characteristics | 6 | 2017 | 220 | 1.630 |
Why?
|
| Nursing Homes | 16 | 2025 | 671 | 1.300 |
Why?
|
| Pediatric Obesity | 3 | 2016 | 100 | 1.270 |
Why?
|
| Environment | 3 | 2017 | 121 | 1.020 |
Why?
|
| Body Mass Index | 5 | 2017 | 861 | 0.930 |
Why?
|
| Stroke | 13 | 2023 | 1184 | 0.870 |
Why?
|
| Health Status | 3 | 2021 | 433 | 0.860 |
Why?
|
| Mexican Americans | 7 | 2015 | 14 | 0.710 |
Why?
|
| Food Supply | 2 | 2017 | 53 | 0.630 |
Why?
|
| Statistics as Topic | 1 | 2017 | 148 | 0.520 |
Why?
|
| Fast Foods | 1 | 2016 | 13 | 0.510 |
Why?
|
| Models, Statistical | 3 | 2016 | 307 | 0.510 |
Why?
|
| Feeding and Eating Disorders | 3 | 2022 | 49 | 0.500 |
Why?
|
| Environment Design | 1 | 2016 | 22 | 0.500 |
Why?
|
| Medicare | 8 | 2025 | 614 | 0.500 |
Why?
|
| Frailty | 3 | 2022 | 130 | 0.480 |
Why?
|
| Male | 42 | 2025 | 29366 | 0.470 |
Why?
|
| Female | 43 | 2025 | 32375 | 0.460 |
Why?
|
| United States | 22 | 2025 | 7696 | 0.460 |
Why?
|
| California | 7 | 2017 | 174 | 0.450 |
Why?
|
| Brain Ischemia | 5 | 2017 | 417 | 0.440 |
Why?
|
| Models, Theoretical | 1 | 2016 | 271 | 0.440 |
Why?
|
| Memantine | 2 | 2024 | 23 | 0.430 |
Why?
|
| Epidemics | 1 | 2013 | 24 | 0.420 |
Why?
|
| Humans | 57 | 2025 | 62455 | 0.420 |
Why?
|
| Cognitive Dysfunction | 3 | 2022 | 330 | 0.410 |
Why?
|
| Arthritis, Psoriatic | 2 | 2023 | 33 | 0.400 |
Why?
|
| Aged | 28 | 2025 | 14203 | 0.400 |
Why?
|
| Aged, 80 and over | 20 | 2025 | 5390 | 0.400 |
Why?
|
| Health Behavior | 1 | 2016 | 466 | 0.390 |
Why?
|
| Analgesics, Opioid | 4 | 2025 | 532 | 0.380 |
Why?
|
| Schools | 5 | 2017 | 159 | 0.370 |
Why?
|
| Spondylarthritis | 2 | 2023 | 40 | 0.370 |
Why?
|
| Antirheumatic Agents | 2 | 2024 | 220 | 0.350 |
Why?
|
| Atrial Fibrillation | 3 | 2024 | 831 | 0.340 |
Why?
|
| Child | 11 | 2024 | 4429 | 0.330 |
Why?
|
| Schizophrenia | 2 | 2021 | 267 | 0.310 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2023 | 331 | 0.310 |
Why?
|
| Drug Prescriptions | 2 | 2021 | 168 | 0.310 |
Why?
|
| Physical Fitness | 3 | 2017 | 91 | 0.310 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2024 | 47 | 0.270 |
Why?
|
| Sexism | 2 | 2024 | 30 | 0.270 |
Why?
|
| Sex Factors | 7 | 2024 | 968 | 0.270 |
Why?
|
| Middle Aged | 21 | 2024 | 17293 | 0.260 |
Why?
|
| Delirium | 2 | 2025 | 56 | 0.260 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2017 | 126 | 0.250 |
Why?
|
| Cross-Sectional Studies | 10 | 2023 | 2529 | 0.250 |
Why?
|
| Stroke Rehabilitation | 2 | 2017 | 50 | 0.240 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2024 | 208 | 0.240 |
Why?
|
| Adolescent | 9 | 2024 | 6145 | 0.240 |
Why?
|
| Anticoagulants | 3 | 2024 | 493 | 0.240 |
Why?
|
| Multimorbidity | 1 | 2025 | 48 | 0.240 |
Why?
|
| Physical Education and Training | 2 | 2017 | 28 | 0.240 |
Why?
|
| Cardiovascular Diseases | 2 | 2024 | 831 | 0.240 |
Why?
|
| Regression Analysis | 5 | 2017 | 497 | 0.230 |
Why?
|
| Risk Factors | 11 | 2024 | 5287 | 0.220 |
Why?
|
| Insurance, Health | 2 | 2022 | 151 | 0.220 |
Why?
|
| Retrospective Studies | 10 | 2025 | 6484 | 0.220 |
Why?
|
| Frail Elderly | 2 | 2022 | 109 | 0.220 |
Why?
|
| Texas | 7 | 2017 | 57 | 0.210 |
Why?
|
| Serotonin and Noradrenaline Reuptake Inhibitors | 1 | 2023 | 11 | 0.210 |
Why?
|
| Hospices | 1 | 2023 | 35 | 0.210 |
Why?
|
| Restaurants | 2 | 2013 | 12 | 0.210 |
Why?
|
| Hospice Care | 1 | 2023 | 65 | 0.200 |
Why?
|
| Dementia | 2 | 2024 | 257 | 0.200 |
Why?
|
| Bulimia | 1 | 2022 | 17 | 0.190 |
Why?
|
| Rheumatology | 1 | 2022 | 66 | 0.190 |
Why?
|
| Prescription Drug Misuse | 1 | 2022 | 21 | 0.190 |
Why?
|
| Activities of Daily Living | 4 | 2017 | 294 | 0.180 |
Why?
|
| Antipsychotic Agents | 1 | 2024 | 302 | 0.180 |
Why?
|
| Geography, Medical | 1 | 2021 | 5 | 0.180 |
Why?
|
| Depression | 2 | 2019 | 883 | 0.180 |
Why?
|
| Age Factors | 7 | 2022 | 1552 | 0.180 |
Why?
|
| Quality of Life | 2 | 2021 | 1216 | 0.180 |
Why?
|
| Depression, Postpartum | 1 | 2023 | 132 | 0.180 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2022 | 476 | 0.170 |
Why?
|
| Gender Identity | 1 | 2021 | 67 | 0.170 |
Why?
|
| Young Adult | 7 | 2024 | 4607 | 0.170 |
Why?
|
| Multiple Myeloma | 1 | 2025 | 348 | 0.170 |
Why?
|
| Psychotic Disorders | 1 | 2021 | 160 | 0.170 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2021 | 706 | 0.160 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 159 | 0.160 |
Why?
|
| Cohort Studies | 5 | 2024 | 2530 | 0.160 |
Why?
|
| Multiple Sclerosis | 1 | 2022 | 217 | 0.160 |
Why?
|
| Anticonvulsants | 1 | 2020 | 104 | 0.160 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 128 | 0.160 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 216 | 0.160 |
Why?
|
| Mental Health Services | 1 | 2022 | 277 | 0.150 |
Why?
|
| Overweight | 2 | 2012 | 249 | 0.150 |
Why?
|
| Epilepsy | 1 | 2020 | 110 | 0.150 |
Why?
|
| Cluster Analysis | 2 | 2023 | 255 | 0.150 |
Why?
|
| Fibrinolytic Agents | 2 | 2017 | 169 | 0.150 |
Why?
|
| Drug Utilization | 1 | 2020 | 210 | 0.150 |
Why?
|
| Adult | 11 | 2024 | 16564 | 0.150 |
Why?
|
| Hypertension | 3 | 2021 | 590 | 0.140 |
Why?
|
| Minority Groups | 1 | 2019 | 139 | 0.140 |
Why?
|
| Substance-Related Disorders | 2 | 2022 | 716 | 0.140 |
Why?
|
| Guideline Adherence | 3 | 2017 | 306 | 0.140 |
Why?
|
| Comorbidity | 4 | 2025 | 1117 | 0.140 |
Why?
|
| Health Status Disparities | 2 | 2024 | 143 | 0.140 |
Why?
|
| Students | 1 | 2019 | 214 | 0.140 |
Why?
|
| Community-Based Participatory Research | 1 | 2017 | 48 | 0.130 |
Why?
|
| Propensity Score | 1 | 2017 | 154 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 717 | 0.130 |
Why?
|
| Cognition Disorders | 2 | 2017 | 220 | 0.130 |
Why?
|
| Spatial Analysis | 1 | 2016 | 9 | 0.130 |
Why?
|
| Socioeconomic Factors | 4 | 2021 | 775 | 0.120 |
Why?
|
| Community Health Services | 1 | 2017 | 126 | 0.120 |
Why?
|
| Recovery of Function | 2 | 2015 | 282 | 0.120 |
Why?
|
| Healthcare Disparities | 2 | 2017 | 348 | 0.120 |
Why?
|
| Noninvasive Ventilation | 1 | 2016 | 70 | 0.120 |
Why?
|
| Bias | 1 | 2016 | 112 | 0.120 |
Why?
|
| Thrombolytic Therapy | 1 | 2016 | 190 | 0.120 |
Why?
|
| Hospitalization | 1 | 2022 | 1338 | 0.120 |
Why?
|
| Mental Disorders | 1 | 2022 | 755 | 0.120 |
Why?
|
| Linear Models | 1 | 2016 | 408 | 0.120 |
Why?
|
| Social Support | 1 | 2017 | 370 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 909 | 0.110 |
Why?
|
| Population Surveillance | 4 | 2017 | 203 | 0.110 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 334 | 0.110 |
Why?
|
| Ischemic Attack, Transient | 1 | 2015 | 96 | 0.110 |
Why?
|
| Obesity | 2 | 2013 | 1227 | 0.110 |
Why?
|
| Treatment Outcome | 6 | 2024 | 5554 | 0.100 |
Why?
|
| Health Promotion | 1 | 2017 | 491 | 0.100 |
Why?
|
| Administration, Oral | 2 | 2024 | 365 | 0.100 |
Why?
|
| Patient Discharge | 3 | 2022 | 505 | 0.100 |
Why?
|
| Telemedicine | 1 | 2017 | 318 | 0.100 |
Why?
|
| Prospective Studies | 4 | 2022 | 3246 | 0.100 |
Why?
|
| Diet | 1 | 2016 | 522 | 0.100 |
Why?
|
| Emergency Medical Services | 1 | 2015 | 260 | 0.090 |
Why?
|
| Policy | 1 | 2012 | 52 | 0.090 |
Why?
|
| Physical Examination | 2 | 2022 | 109 | 0.090 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2016 | 507 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2013 | 476 | 0.090 |
Why?
|
| Geriatric Assessment | 2 | 2022 | 163 | 0.090 |
Why?
|
| Severity of Illness Index | 4 | 2017 | 1537 | 0.090 |
Why?
|
| Legislation, Food | 1 | 2010 | 4 | 0.080 |
Why?
|
| Nutritional Requirements | 1 | 2010 | 20 | 0.080 |
Why?
|
| Ambulatory Care | 2 | 2022 | 310 | 0.080 |
Why?
|
| Pain | 2 | 2023 | 405 | 0.080 |
Why?
|
| Prevalence | 3 | 2020 | 1343 | 0.080 |
Why?
|
| Beverages | 1 | 2010 | 67 | 0.080 |
Why?
|
| Food | 1 | 2010 | 76 | 0.080 |
Why?
|
| Longitudinal Studies | 2 | 2024 | 1247 | 0.080 |
Why?
|
| School Health Services | 1 | 2010 | 64 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2022 | 2439 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2022 | 768 | 0.070 |
Why?
|
| Incidence | 3 | 2015 | 1359 | 0.060 |
Why?
|
| Cognition | 2 | 2023 | 481 | 0.060 |
Why?
|
| Pregnancy | 2 | 2023 | 2307 | 0.060 |
Why?
|
| SEER Program | 1 | 2025 | 74 | 0.060 |
Why?
|
| Delayed-Action Preparations | 1 | 2025 | 115 | 0.060 |
Why?
|
| Comparative Effectiveness Research | 1 | 2024 | 49 | 0.060 |
Why?
|
| Population Health | 1 | 2024 | 17 | 0.060 |
Why?
|
| Censuses | 1 | 2023 | 16 | 0.050 |
Why?
|
| Accidental Falls | 1 | 2025 | 128 | 0.050 |
Why?
|
| Fractures, Bone | 1 | 2025 | 142 | 0.050 |
Why?
|
| Time-to-Treatment | 1 | 2024 | 108 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2017 | 983 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2025 | 860 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2023 | 103 | 0.050 |
Why?
|
| Biological Products | 1 | 2024 | 95 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2024 | 266 | 0.050 |
Why?
|
| Georgia | 1 | 2022 | 87 | 0.050 |
Why?
|
| Albumins | 1 | 2022 | 35 | 0.050 |
Why?
|
| Educational Status | 1 | 2023 | 273 | 0.050 |
Why?
|
| Pain Management | 1 | 2024 | 162 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2024 | 290 | 0.050 |
Why?
|
| Surveys and Questionnaires | 2 | 2022 | 2638 | 0.050 |
Why?
|
| Chronic Pain | 1 | 2024 | 150 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 173 | 0.050 |
Why?
|
| Tobacco Smoking | 1 | 2021 | 20 | 0.050 |
Why?
|
| Multilevel Analysis | 1 | 2021 | 6 | 0.050 |
Why?
|
| Medically Uninsured | 1 | 2021 | 40 | 0.050 |
Why?
|
| Age of Onset | 1 | 2021 | 175 | 0.040 |
Why?
|
| Myocardial Revascularization | 1 | 2021 | 75 | 0.040 |
Why?
|
| Data Collection | 1 | 2022 | 383 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2024 | 851 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 380 | 0.040 |
Why?
|
| Long-Term Care | 1 | 2021 | 177 | 0.040 |
Why?
|
| Cause of Death | 1 | 2021 | 220 | 0.040 |
Why?
|
| Mortality | 1 | 2021 | 160 | 0.040 |
Why?
|
| Psychometrics | 1 | 2022 | 376 | 0.040 |
Why?
|
| Patient Admission | 1 | 2021 | 189 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 142 | 0.040 |
Why?
|
| Medicare Part D | 1 | 2020 | 37 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2021 | 161 | 0.040 |
Why?
|
| Sexual Behavior | 1 | 2021 | 192 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 724 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2021 | 278 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2019 | 252 | 0.040 |
Why?
|
| Biomarkers | 1 | 2024 | 1379 | 0.040 |
Why?
|
| Aging | 1 | 2024 | 738 | 0.040 |
Why?
|
| Mental Status Schedule | 1 | 2017 | 19 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 1634 | 0.040 |
Why?
|
| Infant | 1 | 2022 | 1591 | 0.030 |
Why?
|
| Michigan | 1 | 2017 | 43 | 0.030 |
Why?
|
| Registries | 1 | 2021 | 869 | 0.030 |
Why?
|
| Medicaid | 1 | 2021 | 359 | 0.030 |
Why?
|
| Self Report | 1 | 2019 | 370 | 0.030 |
Why?
|
| Algorithms | 1 | 2022 | 1003 | 0.030 |
Why?
|
| Time Factors | 1 | 2024 | 3737 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 535 | 0.030 |
Why?
|
| Survivors | 1 | 2017 | 168 | 0.030 |
Why?
|
| Venous Thrombosis | 1 | 2017 | 113 | 0.030 |
Why?
|
| Logistic Models | 1 | 2019 | 1272 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2015 | 119 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2019 | 516 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 561 | 0.030 |
Why?
|
| Crime | 1 | 2015 | 53 | 0.030 |
Why?
|
| Medical Records | 1 | 2015 | 137 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2016 | 738 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2017 | 513 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 1064 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 1076 | 0.030 |
Why?
|
| Epidemiological Monitoring | 1 | 2013 | 31 | 0.030 |
Why?
|
| Brain | 1 | 2022 | 1546 | 0.030 |
Why?
|
| Poverty | 1 | 2015 | 295 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 2141 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 725 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 416 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2014 | 211 | 0.020 |
Why?
|
| Health Surveys | 1 | 2013 | 311 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 389 | 0.020 |
Why?
|
| Survival Rate | 1 | 2013 | 837 | 0.020 |
Why?
|
| Los Angeles | 1 | 2010 | 11 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 2033 | 0.020 |
Why?
|
| State Government | 1 | 2010 | 31 | 0.020 |
Why?
|
| Commerce | 1 | 2010 | 56 | 0.020 |
Why?
|